| scholarly article | Q13442814 |
| P50 | author | James Figarola | Q77315566 |
| Timothy Synold | Q78536675 | ||
| P2093 | author name string | Bixin Xi | |
| John Termini | |||
| Daniel Tamae | |||
| Gerald E Wuenschell | |||
| Samuel Rahbar | |||
| P2860 | cites work | Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells | Q24291537 |
| Brief history of glyoxalase I and what we have learned about metal ion-dependent, enzyme-catalyzed isomerizations | Q28189975 | ||
| Expression of glyoxalase I and II in normal and breast cancer tissues | Q28190025 | ||
| Studies of an unusual hemoglobin in patients with diabetes mellitus | Q28256304 | ||
| Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. | Q31991133 | ||
| Facts and artifacts in the measurement of oxidative base damage to DNA. | Q33546919 | ||
| Comparison of the levels of 8-hydroxyguanine in DNA as measured by gas chromatography mass spectrometry following hydrolysis of DNA by Escherichia coli Fpg protein or formic acid | Q33617525 | ||
| N(2)-(1-Carboxyethyl)deoxyguanosine, a nonenzymatic glycation adduct of DNA, induces single-strand breaks and increases mutation frequencies | Q33877748 | ||
| The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. | Q34361173 | ||
| Teratogenicity of 3-deoxyglucosone and diabetic embryopathy | Q34481939 | ||
| Utility of hemoglobin A1c in predicting diabetes risk | Q34733790 | ||
| Applications of mass spectrometry for quantitation of DNA adducts | Q34958628 | ||
| Stereospecific synthesis and characterization of oligodeoxyribonucleotides containing an N2-(1-carboxyethyl)-2'-deoxyguanosine | Q35205169 | ||
| Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring | Q35594333 | ||
| The metabolic syndrome: A high-risk state for cancer? | Q35607405 | ||
| Protein glycation: a firm link to endothelial cell dysfunction | Q35857303 | ||
| A case-control study of diabetes mellitus and cancer risk | Q36080130 | ||
| Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection | Q36307099 | ||
| Methylglyoxal in food and living organisms. | Q36653426 | ||
| Analysis of DNA-bound advanced glycation end-products by LC and mass spectrometry | Q36680052 | ||
| Detection of DNA-bound advanced glycation end-products by immunoaffinity chromatography coupled to HPLC-diode array detection | Q40295068 | ||
| A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed | Q40296262 | ||
| Methylglyoxal modification of mSin3A links glycolysis to angiopoietin-2 transcription | Q40329542 | ||
| Genotoxicity of advanced glycation end products: involvement of oxidative stress and of angiotensin II type 1 receptors | Q40394729 | ||
| Formation of DNA adducts in human buccal epithelial cells exposed to acetaldehyde and methylglyoxal in vitro | Q41053676 | ||
| The metabolism of acetone in rat. | Q42255685 | ||
| The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins. | Q42282865 | ||
| Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography | Q43851417 | ||
| LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats | Q44502869 | ||
| Similar mutagenicity of photoactivated porphyrins and ultraviolet A radiation in mouse embryonic fibroblasts: involvement of oxidative DNA lesions in mutagenesis. | Q45174872 | ||
| Identification of alpha-dicarbonyl scavengers for cellular protection against carbonyl stress | Q45712472 | ||
| Advanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidine | Q46613227 | ||
| Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats | Q46613239 | ||
| N2-carboxyethyl-2'-deoxyguanosine, a DNA glycation marker, in kidneys and aortas of diabetic and uremic patients | Q46891104 | ||
| Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients | Q46966714 | ||
| Identification of DNA adducts of methylglyoxal | Q46987843 | ||
| Novel inhibitors of glycation and AGE formation | Q47572970 | ||
| Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. | Q47785594 | ||
| Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions. | Q52078784 | ||
| Comparison of different methods of measuring 8-oxoguanine as a marker of oxidative DNA damage | Q60490626 | ||
| Modification of the glyoxalase system in streptozotocin-induced diabetic rats | Q60786696 | ||
| Detection of methylglyoxal as a degradation product of DNA and nucleic acid components treated with strong acid | Q71138592 | ||
| Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin | Q72352188 | ||
| A role for DNA mutations in diabetes-associated teratogenesis in transgenic embryos | Q72390489 | ||
| Identification of N2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycosylation end product | Q72403672 | ||
| Methylglyoxal induces G:C to C:G and G:C to T:A transversions in the supF gene on a shuttle vector plasmid replicated in mammalian cells | Q73960331 | ||
| DNA-glycation leads to depurination by the loss of N2-carboxyethylguanine in vitro | Q77659616 | ||
| Influences of DNA isolation and RNA contamination on carcinogen-DNA adduct analysis by 32P-postlabeling | Q77769208 | ||
| Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum | Q77928208 | ||
| P433 | issue | 11 | |
| P921 | main subject | electrospray ionization | Q902061 |
| P304 | page(s) | 2148-2155 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | Chemical Research in Toxicology | Q473530 |
| P1476 | title | Advanced glycation end products of DNA: quantification of N2-(1-Carboxyethyl)-2'-deoxyguanosine in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry | |
| P478 | volume | 21 |
| Q37200477 | 5'-O-Alkylpyridoxamines: Lipophilic Analogues of Pyridoxamine Are Potent Scavengers of 1,2-Dicarbonyls |
| Q37097143 | A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease |
| Q36431367 | A quantitative assay for assessing the effects of DNA lesions on transcription |
| Q36444967 | Chemical structure and properties of interstrand cross-links formed by reaction of guanine residues with abasic sites in duplex DNA |
| Q35987220 | Conservation of thiol-oxidative stress responses regulated by SigR orthologues in actinomycetes. |
| Q37694160 | DNA Advanced Glycation End Products (DNA-AGEs) Are Elevated in Urine and Tissue in an Animal Model of Type 2 Diabetes. |
| Q35591266 | Detection of 7-(2'-carboxyethyl)guanine but not 7-carboxymethylguanine in human liver DNA. |
| Q39285661 | Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention |
| Q42143277 | Endogenous mitochondrial oxidative stress in MnSOD-deficient mouse embryonic fibroblasts promotes mitochondrial DNA glycation |
| Q39708396 | Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance |
| Q35534535 | Increased DNA dicarbonyl glycation and oxidation markers in patients with type 2 diabetes and link to diabetic nephropathy |
| Q47828871 | Inhibition of GLO1 in Glioblastoma Multiforme Increases DNA-AGEs, Stimulates RAGE Expression, and Inhibits Brain Tumor Growth in Orthotopic Mouse Models. |
| Q34983879 | Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products |
| Q37304675 | Mass Spectrometry-Based Quantitative Strategies for Assessing the Biological Consequences and Repair of DNA Adducts |
| Q36979806 | Mass spectrometry of structurally modified DNA. |
| Q41789554 | Mutagenesis and repair induced by the DNA advanced glycation end product N2-1-(carboxyethyl)-2'-deoxyguanosine in human cells |
| Q42326436 | Mutagenic potential of DNA glycation: miscoding by (R)- and (S)-N2-(1-carboxyethyl)-2'-deoxyguanosine |
| Q37455830 | Oxidative stress in diabetes and Alzheimer's disease |
| Q33638705 | Quantification of N2-carboxymethyl-2'-deoxyguanosine in calf thymus DNA and cultured human kidney epithelial cells by capillary high-performance liquid chromatography-tandem mass spectrometry coupled with stable isotope dilution method |
| Q36390390 | Quantitation of DNA adducts by stable isotope dilution mass spectrometry |
| Q89484239 | RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer-a Review |
| Q38394355 | The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases |
Search more.